| Gastrointestinal dysfunctions in Parkinson's disease: symptoms and treatments | 4,306 |
| Pathophysiology of motor dysfunction in Parkinson's disease as the rationale for drug treatment and rehabilitation | 4,041 |
| DBS Programming: an evolving approach for patients with Parkinson's disease | 2,773 |
| LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson disease | 2,567 |
| Progressive resistance exercise and Parkinson's disease: A review of potential mechanisms | 1,983 |
| Living with Parkinson's, the emerging role of occupational therapy. | 1,964 |
| N-Acetyl Cysteine Protects against Methamphetamine-induced Dopaminergic Neurodegeneration via Modulation of Redox Status and Autophagy in Dopaminergic cells | 1,803 |
| Comparing the Mini-BESTest with the Berg Balance Scale to Evaluate Balance Disorders in Parkinson's Disease | 1,788 |
| METHAMPHETAMINE AND PARKINSON´S DISEASE | 1,748 |
| DOPAMINE OXIDATION AND AUTOPHAGY | 1,415 |
